Running title: IL4-driven microglia modulate neurogenesis and stress resilience
Introduction
It is well-known that prolonged stress can induce cascading effects in the inflammatory system and lead to neuropsychiatric disorders, such as depression and anxiety, which can affect neurogenesis 1 . New neurons are generated throughout adulthood in two regions of the brain, the dentate gyrus (DG) in the hippocampus and the subventricular zone 2 . Neural stem/progenitor cells (NSPCs) undergo proliferation, differentiation, survival and maturation into new neurons, which eventually integrate into the neural network 3 . These processes are regulated negatively by stressful experiences and positively by treatment with antidepressant drugs through altering the neurogenic microenvironment 2 . These adult-born neurons are critical for mood control and behavioral output 2, 4 . Alterations in the magnitude of this continuous production of new neurons are associated with both the pathophysiology of depression and the efficacy of antidepressants 1, 5, 6 .
Microglia, the principal immune cells in the brain, play central roles in immune surveillance and maintenance of brain homeostasis 7 . Studies have shown that microglia can regulate neurogenesis by secreting various factors that modulate the neurogenic microenvironment 8, 9 . Under stress or pathological conditions, microglia secrete inflammatory mediators that disrupt neuronal function and impair neurogenesis, increasing the vulnerability to stress and promoting the occurrence and development of depression [9] [10] [11] . On the other hand, recent evidence showed that microglial 'alternative activation' leads to an increase in adult neurogenesis in response to exercise and environmental enrichment, which contribute to normal 5 behavior 12, 13 . The role of microglia in neurogenesis depends on the balance between the soluble factors released by microglial cells under different activation scenarios. Microglial brain-derived neurotrophic factor (BDNF) is an important mediator of microglia-to-neuron communication, and contributes to many facets of brain function via its high-affinity receptor, tropomyosin-related kinase B (TrkB) 14, 15 . Microglial BDNF may also be involved in neurobehavioral plasticity and neurogenesis, and therefore may underlie the pathophysiology of depression 12, 16 .
Interleukin 4 (IL4) is a multifunctional cytokine expressed in the brain and is involved in the regulation of inflammatory responses and physiological processes of the central nervous system (CNS) [17] [18] [19] . IL4 deficiency weakens the resilience against stress-induced depression, while increasing IL4 levels can alleviate depressive-like behaviors [20] [21] [22] [23] . Studies have shown that IL4 can reprogram microglia toward an Arg1 + phenotype for maintaining brain homeostasis, neuroprotection and tissue repair [24] [25] [26] [27] .
However, the effects of IL4-induced Arg1 + microglia on neurogenesis and stress resilience are poorly understood.
In light of the role of microglia in the pathogenesis of depressive disorders, we hypothesized that promoting a neuroprotective phenotype of microglia would improve stress responses and depressive behaviors. Consistent with this expectation, we found that in mice exposed to chronic mild stress (CMS), overexpression of hippocampal IL4 drove Arg1 + microglia to promote neurogenesis, which in turn attenuated depressive-like behaviors. 6 Animals CX 3 CR1 Cre/ER mice on a C57BL/6J background were purchased from The Jackson Laboratory. Wild-type (WT) C57BL/6J mice were purchased from the Laboratory Animal Center of Sichuan Academy of Medical Sciences (Chengdu, China). All mice were housed under standard conditions with free access to food and water. All animal experiments were approved by the Ethics Committee of the University of Electronic Science and Technology of China and carried out in strict accordance with the US National Institutes of Health Guide for the Care and Use of Laboratory Animals (8th edition, revised 2010).
Material and methods

Chronic Mild Stress (CMS)
Male mice aged 8-10 weeks at the start of experiments were caged individually and subjected to a CMS protocol 10 . To establish an animal model of depression, the CMS paradigm was conducted over a 4-week period and consisted of daily exposure to three stressors in random order. To screen the vulnerable animals, the CMS paradigm was conducted over a 3-week period. These stressors included empty water bottles (12 h), food deprivation (12 h), tail clipping (10 min), restraint (2 h), lights-off for 3 h during the daylight phase, cage shaking (1 h), cage tilting (45°, 24 h), reversal of the light-dark cycle (24 h), strobe lighting (12 h), damp bedding (24 h) and a soiled cage (24 h).
Animal screening
Mice were subjected to CMS for 3 weeks, then subdivided as described 28 into groups of high-susceptible (HS) or low-susceptible (LS) animals. The mice were 7 considered LS if their immobility time in the forced swim test and tail suspension test, and their sucrose intake (see below) were within one standard deviation of the mean values for control mice. If these values fell outside this threshold, animals were considered HS.
Expression systems and stereotactic injection
Recombinant adeno-associated virus (rAAV) 2/9 was produced by transfecting 293T cells with three plasmids: an AAV vector expressing both IL4 and enhanced green fluorescent protein (EGFP), IL4 alone or EGFP alone; an AAV helper plasmid (pAAV Helper); and an AAV Rep/Cap expression plasmid. At 72 h after transfection, cells were collected and lysed using a freeze-thaw procedure. AAV-IL4 or AAV were diluted to 1 × 10 10 transforming units (TU)/mL and injected (0.5 µL ) bilaterally in the hippocampus (Bregma: 2.3 mm, L: 1.8 mm, V: 2.0 mm).
To downregulate expression of the IL4 receptor α-chain (IL4Rα) in hippocampal microglia, a lentivirus encoding a short hairpin RNA (shRNA) against the receptor was constructed as described 29 . The lentivirus contained the cassette u6-LoxP-stop-LoxP-shRNA-IL4Rα. To construct shRNA-IL4Rα, oligonucleotides containing antisense sequences were connected with a hairpin loop, followed by a poly termination signal. The sequences targeting IL4Rα (GenBank accession: NM_001008700, ID: 16190) in this experiment were 5′-GCG CTG TAT GGA GCT GTT TGA-3′ and 5′-TCA AAC AGC TCC ATA CAG CGC-3′.
For in vivo viral injections, viral vectors were bilaterally targeted to the hippocampus (Bregma: 2.3 mm, L: 1.8 mm, V: 2.0 mm). Animals received 8 intracranial viral injections while under 10% pentobarbital anesthesia using a Kopf stereotactic apparatus. Mice were secured using ear bars and a head holder. A Micro-1 microsyringe pump controller (RWD life science) was used to inject viral vectors. A 33-GA needle was lowered 2 mm over 5 min resulting in delivery of 0.25 μL viral vectors (2.5 × 10 9 TU) into each hippocampus. After injection, the syringe was held in place for 5 min to avoid back-flow. Animals were sutured and placed on a heating pad for recovery. Mice behavior was analyzed at 2 weeks after these injections (see below). Tamoxifen (Sigma) was dissolved in warm sunflower seed oil at a concentration of 40 mg/ml and injected intraperitoneally at 100 mg/kg for 7 days to induce Cre recombinase expression.
Behavioral analyses
Sucrose preference test (SPT)
The sucrose preference test was performed as described 10 . Mice were individually housed, deprived of food and water for 12 h, and then given access to 1% sucrose solution (A) and water (B) for 2 h. The bottle positions were switched daily to avoid a side bias. The sucrose preference was calculated each week for each mouse using the formula: 100 × [VolA / (VolA + VolB)]. The sucrose consumption was normalized to body weight for each mouse.
Locomotor activity test (LAT)
Each mouse was placed in an autonomous movement instrument with a 36-point infrared ray passive sensor system (ZZ-6, Taimeng Tech, Chengdu, China). All mice were allowed to habituate to the environment for 1 min before the test. The total 9 locomotor activity (standing and movement) was automatically recorded for each mouse during 10 min.
Forced swim test (FST)
Each mouse was placed for 15 min in a cylinder containing 15 cm of water. After 24 h, the animals were placed again in the cylinder for 6 min. The duration of immobility (including staying afloat and movements to stay afloat) was measured using FST100 software (Taimeng Tech) during the last 4 min of swimming time.
Tail suspension test (TST)
The TST was performed as described 10 . Mice were elevated by securing the tail 30 cm above the ground with adhesive plaster. Mice were isolated from one another using a black cardboard. Mice were recorded for 6 min, and time spent immobile during that period was determined by observers blind to mouse group allocations.
Coat score assay
The physical state of the fur was evaluated weekly in the coat score assay as described 30 . The total coat score was measured as the sum of the scores for seven different body parts: head, neck, forepaws, dorsal coat, ventral coat, hindpaws and tail.
For each area, a score of 1 was given for a well-groomed coat and a score of 0 was given for an unkempt coat.
Novelty-suppressed feeding test (NSFT)
Mice were deprived of food and water for 12 h before the test, and then each mouse was placed for 5 min in a rectangular chamber (40 × 40 × 30 cm) containing a sugar pill in the center of the chamber. The time it took for a mouse to pick up the 10 sugar with its forelimb was recorded as latency using a camera system.
Open field test (OFT)
The mice were gently placed in the center of a rectangular chamber (40 × 40 × 30 cm) and left to explore the area for 5 min. The digitized image of the path taken by each mouse was stored, and the locomotion activity and time spent in the center were analyzed post hoc for each mouse using OFT100 software (Taimeng Tech).
Gene expression analysis
Total RNA was isolated from mouse hippocampus using Isol-RNA Lysis Reagent (5 Prime). Quantitative real-time PCR was performed, and gene expression was quantified using the -∆∆Ct method. Primer sequences are listed in Table S1 .
Enzyme-linked immunosorbent assay (ELISA)
Hippocampal sections of mice were sonicated in RIPA-buffer containing protease inhibitors. Cytokine concentrations were quantified using ELISA kits (QuantiCyto, China) according to the manufacturer's protocol. Detection limits were 8 pg/mL for IL4 and Arg1, and 4 pg/mL for iNOS, TGFß and BDNF.
Western blotting
Hippocampal tissue or isolated hippocampal microglia were sonicated in RIPA-buffer containing protease inhibitors. Protein samples were run on 12% Tris-glycine SDS-PAGE gels, transferred to PVDF membrane (0.2 or 0.45 μm), and blotted with antibodies (Abcam) against IL4 (1:1000), IL4Rα (1:1000), STAT6
(1:800), pSTAT6 (1:800) Arg1 (1:1000), TrkB (1:1000) and β-actin (1:20,000).
Primary antibody was incubated overnight at 4°C, and secondary antibodies (1:10,000, 11 Abcam) were incubated for 2 h at room temperature. Signals were developed using the ECL-Plus kit (Millipore, USA). Densitometry was performed to quantify signal intensity using ImageJ software (version 1.45 J; National Institutes of Health, Bethesda, MD, USA).
BrdU incorporation
To determine cell proliferation in the brain, mice received two intraperitoneal injections of BrdU (50 mg/kg) 8 h apart. To examine progenitor proliferation, mice were sacrificed 24 h after the second injection; to examine progenitor differentiation, mice were sacrificed 1 week after BrdU injection. For examination of neuronal survival in the granular layer, animals were injected with a double dose of BrdU and sacrificed 4 weeks after injection.
Tissue preparation and immunohistochemistry
Tissue preparation and staining were performed as described 10 using the antibodies listed in Table S2 .
Isolation of microglia from hippocampus
Hippocampus was isolated from the brain and homogenized into single-cell suspensions, from which microglia were isolated on a Percoll density gradient as described 31 . In brief, the hippocampus was homogenized, and cell pellets were resuspended in 70% isotonic Percoll. A discontinuous Percoll density gradient (70%, 50%, 35%, 0%) was layered and centrifuged for 20 minutes at 2000g. Enriched microglia were collected from the interphase between 70% and 50% Percoll. Of the cells recovered from this Percoll interphase, approximately 90% of the cells were 12 CD45 int -CD11b + microglia.
Flow Cytometry
Cells were assayed for surface antigens by flow cytometry as previously described 32 . These microglia were labeled with FITC anti-mouse CD45 (2 µg/mL, Biolegend, USA), APC anti-mouse CD11b (5 µg/mL, Biolegend, USA), APC/Cyanine7 anti-mouse CD86 (1 µg/mL, Biolegend, USA), and PerCP/Cyanine 5.5 CD206 (5 ug/mL, Biolegend, USA) antibodies for 30 min at room temperature. A four-laser Becton-Dickinson FACS Calibur (BD Biosciences) was used to collect the data, and FlowJo software was used for analysis.
RNA sequencing
Total RNA was extracted from hippocampal tissue using TRIzol® Reagent according to the manufacturer's instructions (Invitrogen) and genomic DNA was removed using DNase I (TaKara). Then RNA quality was determined by 2100 Bioanalyser (Agilent) and quantified using the ND-2000 (NanoDrop Technologies).
Only high-quality RNA samples (OD260/280 = 1.8 ~ 2.2, OD260/230 ≥ 2.0, RIN ≥ 6.5, 28S:18S ≥ 1.0, > 2 μg) were used to construct the sequencing library.
RNA purification, reverse transcription, library construction and sequencing were performed according to the manufacturer's instructions (Illumina, San Diego, CA). The RNA-seq transcriptome library was prepared following TruSeqTM RNA sample preparation Kit from Illumina (San Diego, CA) using 1μg of total RNA. Briefly, mRNA was isolated according to poly A selection method by oligo (dT) beads and then fragmented using fragmentation buffer. Double-stranded cDNA was 13 synthesized using a SuperScript double-stranded cDNA synthesis kit (Invitrogen, CA) with random hexamer primers (Illumina). Then the synthesized cDNA was subjected to end-repair, phosphorylation and 'A' base addition according to Illumina's library construction protocol. The size of libraries was selected for cDNA target fragments of 200-300 bp on 2% Low Range Ultra Agarose followed by PCR amplified using Phusion DNA polymerase (NEB) for 15 cycles. After quantification by TBS380, paired-end RNA-seq library was sequenced on the Illumina NovaSeq 6000 (2 × 150bp read length). All RNA-Seq raw data were uploaded in Sequence Read Archive (SRA: PRJNA602066).
Analysis of RNA sequencing data
RNA-Seq data were initially filtered to obtain clean data, including removing reads with adaptors, reads with more than 10% unknown bases or low quality reads (the percentage of low quality bases is over 50% in the read). To identify differential expression genes (DEGs) between two different samples, the expression level of each transcript was calculated according to the fragments per kilobase of exon per million mapped reads (FPKM) method. The package software Empirical analysis of Digital Gene Expression in R (EdgeR) was utilized for differential expression analysis. In addition, functional-enrichment analysis including GO and KEGG was performed to identify which DEGs were significantly enriched in GO terms and metabolic pathways at Bonferroni-corrected P-value ≤ 0.05 compared with the whole-transcriptome background. GO functional enrichment and KEGG pathway analysis were carried out by Goatools. 14 
Cell culture and treatments
Neural stem/progenitor cells (NSPCs) and primary microglia were cultured as described 10 . Microglia were treated with IL4 (20 ng/mL) or IFNγ (10 ng/mL) for 24 h to induce microglial activation 24 . To assay the short-term effects of microglia on NSPCs, NSPCs were co-cultured with microglia in transwell plates for 24 h in experiments to examine proliferation, or for 3 days in experiments to examine differentiation. To assay the long-term effects of microglia on NSPCs, NSPCs were cultured in microglia-conditioned medium (M-CM) for 24 h in experiments to examine proliferation, or for 7 days in experiments to examine differentiation. The BDNF pathway was blocked using anti-BDNF antibody (1 μg/mL) or BDNF receptor antagonist K252a (100 ng/mL).
Imaging and statistical analyses
Images were acquired using a Zeiss AxioImager Z1, and cells were counted manually. Areas of Iba1 or GFAP staining and relative fluorescence intensity were analyzed using Image J software. Branches of microglia were measured using Image-Pro Plus 6.0 (Media Cybernetics, USA). To quantify total cell populations in the hippocampus (microglia, astrocytes, BrdU + cells, BrdU + -DCX + cells and BrdU + -NeuN + cells), every sixth section (25 μm thick) of the brain containing hippocampus was selected and immunostained. Total numbers of positive cells in all slices per animal were multiplied by six to estimate the number of cells per hippocampus. For measurement of the volume of hippocampus, DG and granule cell layer (GCL), every sixth section (25 μm thick) of the brain containing hippocampus 15 was selected and labelled with DAPI. Total area of hippocampus, DG or GCL in all slices per animal was multiplied by six to estimate the volume of hippocampus, DG and GCL.
All quantitative results were expressed as mean ± SEM. Data were plotted and analyzed statistically using GraphPad Prism 7.0. Potential differences between the mean values were evaluated using one-or two-way analysis of variance (ANOVA), followed by the least significant difference (LSD) test for post hoc comparisons assuming equal variances. Independent-samples t tests were used to compare the differences between two groups, unless otherwise specified. Asterisks were used to indicate significance: *p < 0.05, **p < 0.01, and ***p < 0.001. Values > 0.05 were considered not significant (n.s.).
Results
Vulnerability to stress is associated with reduced IL4 signaling in the hippocampus
Following exposure to CMS for 3 weeks, C57BL/6J mice were separated into HS and LS subpopulations according to their sucrose preference and immobility time in TST and FST (Fig. 1a ). These subpopulations were confirmed by open field test, body weight and coat score ( Fig. S1 ). We examined cytokines, chemokines and neurotrophic factors related to neuroinflammatory processes in the hippocampus and prefrontal cortex, and found that levels of IL4 mRNA in the hippocampus were elevated in LS mice but reduced in HS mice, compared to the control mice ( Fig. 1b ).
In particular, the change in IL4 protein levels in the hippocampus was the most significant outcome (Fig. 1c ). Western blotting showed that hippocampal IL4-STAT6 16 signaling was increased in LS mice, but decreased in HS mice ( Fig. 1d ). Correlation analysis showed that the IL4 concentration in the hippocampus positively correlated with sucrose preference and negatively correlated with immobility time in TST ( Fig.   1e ), suggesting that the vulnerability of mice to CMS was associated with reduced IL4 signaling in the hippocampus.
Overexpression of IL4 in the hippocampus induced microglial Arg1 + phenotype
Since IL4 is a rapidly degraded glycoprotein of about 20 kDa that cannot cross the blood-brain barrier 33 , we specifically increased IL4 levels in the hippocampus using rAAV vectors combined with Ef1α promoter encoding murine IL4 to investigate the effect of brain-derived IL4 on depressive-like behaviors. The AAV2/9-IL4-EGFP is more highly infectious to cultured neurons than to astrocytes and microglia ( Fig.   S2 ). AAV2/9-IL4-EGFP was stereotactically injected into the hippocampus of C57BL/6J mice, such that EGFP would be co-expressed with IL4. EGFP was mainly localized in NeuN + cells of the hippocampus (Fig. 2a ). Another construct encoding murine IL4 without EGFP (AAV-IL4) was stereotactically injected into the hippocampus; in this case, IL4 expression in the hippocampus was confirmed by quantitative PCR, ELISA, and IL4Rα, STAT6 and pSTAT6 were examined with Western blotting at 2 weeks after injection of the recombinant systems ( Fig. 2b and   S3 ). AAV-IL4 mice were exposed to CMS for 4 weeks and the expression of IL4 in the hippocampus was confirmed again (Fig. 2c ).
Transcriptome sequencing was performed to explore the whole transcriptome levels of the hippocampus during AAV-IL4 and/or CMS treatment by RNA 17 sequencing (RNA-seq) ( Fig. S4 ). There were 65 genes differentially expressed in AAV + CMS mice when compared to AAV mice (31 showed upregulation and 34 downregulation). Most of these genes are involved in stress responses. There were 760 genes with differential expression in AAV-IL4 + CMS mice compared to AAV + CMS mice (597 showed upregulation and 163 downregulation). Most of these genes are involved in immunomodulation ( Fig. 2d) . Several of the genes were confirmed to be significantly and differentially expressed in the hippocampus by qPCR ( Fig. 2e ).
Among them, Arg1 was the most significantly upregulated both at the gene and protein levels after AAV-IL4 injection with or without CMS treatment ( Fig. 2f and Fig.   S5 ). Further, the expression of Arg1 was strongly correlated with hippocampal IL4 levels ( Fig. S5) .
To determine the cell source of Arg1, we performed cell localization of Arg1.
Immunohistochemical staining showed that Arg1 was located in hippocampal Iba1 + cells, and the number of Arg1 + microglia was significantly elevated in CA1, CA3 and DG of hippocampus in AAV-IL4 mice under both non-stress and stress conditions ( Fig.   2g and 2h). Microglia in the hippocampus of AAV-IL4 mice showed obvious morphological changes, manifested by decreased processes and larger somata ( Fig. 2i and S6). To assay the population of microglial subsets, flow-cytometry was performed on single cell suspensions of the whole hippocampus. The results revealed that microglia, in the form of CD45 int -CD11b + cells, increased significantly in CMS-exposed mice and AAV-IL4 mice, corroborating the presence of microglia proliferation. The CD86 + -CD206 + microglia were significantly increased in the 18 hippocampus of AAV-IL4 mice ( Fig. 2j and 2k ).
Knockdown of microglial IL4Rα decreased Arg1 + microglia phenotype in the hippocampus
To confirm the effects of IL4 on microglial phenotype, knockdown of the microglial IL4 receptor was performed. The lentivirus encoding IL4Rα-targeting shRNA (LV-U6-LoxP-CMV-EGFP-LoxP-IL4Rα shRNA) was first synthesized. The transfection efficiency of LV-U6-LoxP-CMV-EGFP-LoxP-IL4Rα shRNA on microglia was then confirmed (Fig. S7) . To test the efficiency of Cre recombinant enzyme, the hippocampi of CX 3 CR1 CreER mice were transfected with LV-U6-LoxP-CMV-EGFP-LoxP-IL4Rα shRNA, and then treated with tamoxifen to specifically recognize the LoxP site ( Fig. S8a ). After tamoxifen treatment for 1 week, the green fluorescent protein in microglia was cut efficiently (Fig. 3a ). Next, we synthesized another lentivirus vector (LV-U6-LoxP-Stop-LoxP-IL4Rα shRNA) without the expression of EGFP to specifically downregulate microglial IL4Rα in hippocampus ( Fig. S8b ). After tamoxifen treatment for 1 week, the microglial IL4Rα, STAT6, pSTAT6 and Arg1 were significantly reduced in the hippocampus (Fig. 3b ).
We thus achieved IL4Rα shRNA specific targeting of hippocampal microglia (shIL4Rα/M).
Knockdown of microglial IL4Rα decreased the number of Arg1 + microglia phenotype in the hippocampus of AAV or AAV-IL4 CX 3 CR1 CreER mice, under both non-stress and stress conditions ( Fig. 3c and 3d) . Remarkably, knockdown of microglial IL4Rα suppressed the proliferation of microglia, the decrease in length of 19 branches and increase in area of Iba1 + cells in the hippocampus of AAV or AAV-IL4 CX 3 CR1 CreER mice, under non-stress and stress conditions ( Fig. 3e-3g ).
IL4-driven Arg1 + microglia enhanced hippocampal neurogenesis in CMS-exposed mice GO enrichment analysis of differentially expressed genes in transcriptome sequencing showed that CMS affected expression of genes associated with stress response, apoptosis, and synaptic function. Overexpression of IL4 in the hippocampus of CMS-exposed mice resulted in changes related to neurogenesis, such as the nutrient metabolism, Notch and Wnt pathways (Fig. 4a ).
We examined hippocampal neurogenesis, including proliferation, differentiation, survival and maturity of NSPCs. The results showed that CMS-exposed mice displayed a striking reduction in neuronal differentiation, as shown by a lower number of BrdU + -DCX + cells, and a slower neuronal differentiation rate compared with unstressed controls. Overexpression of IL4 with AAV-expression system in the hippocampus reversed CMS-induced deficits in neurogenesis. Meanwhile, knockdown of microglial IL4Rα decreased BrdU + -DCX + cells and the percentage of BrdU + -DCX + cells out of total BrdU + cells in AAV or AAV-IL4 mice (Fig. 4b -4d and Fig. S9 ).
To assay the extent of survival and maturity of proliferative cells, the proliferating cells were labeled with BrdU before CMS exposure (Fig. 4e ). Reduced (Fig. 4f, 4g and Fig. S9 ).
Considering that microglia can modulate neurogenesis, we collected the conditioned medium of microglia isolated from the hippocampus of AAV mice or AAV-IL4 mice under stress or non-stress conditions to culture NSPCs (Fig. 4h ). In (Fig. 4i and Fig. S10 ). This suggested that CMS-induced microglia suppressed the proliferation of NSPCs, and IL4-driven microglia promoted the proliferation of NSPCs in the hippocampus of CMS-exposed mice.
In NSPCs differentiation assays, we found that M-CM from mice injected with However, there were no significant effects on proliferation and differentiation of NSPCs after they were treated with IL4 when compared with phosphate-buffered saline (PBS) (Fig. S11 ).
IL4-driven microglia enhance neurogenesis via a BDNF-dependent pathway
Next we explored how IL4-driven Arg-1 + microglia may promote neurogenesis.
In the transcriptome study, the expression of Bdnf was significantly upregulated in the brain of AAV-IL4 + CMS mice. Concurrently, nutrient component metabolism and BDNF receptor signaling-related genes were enriched to a high degree (Fig. 5a ). This suggested that IL4-driven microglia may promote hippocampal neurogenesis through BDNF signaling pathways. We confirmed that BDNF concentration was maintained at a high level in the hippocampus of AAV-IL4 mice in the presence or absence of CMS treatment (Fig. 5b) . The signal of BDNF receptor (TrkB) in the hippocampus also was strengthened by overexpression of IL4 (Fig. S12 ). Immunohistochemistry showed that BDNF accumulated in large quantities around Iba1 + cells in the hippocampus of AAV-IL4 mice (Fig. 5c ). Notably, we found BDNF widely distributed in both intracellular and extracellular compartments of Arg1 + microglia (Fig. 5d ). These results suggested that IL4-driven microglia could synthesize and secrete more BDNF.
Knockdown of microglial IL4Rα significantly reduced BDNF expression in the hippocampus of AAV-IL4 mice ( Fig. 5e and 5f ). Correlation analysis showed that 22 there was a significant positive correlation between the number of BrdU + -DCX + cells and the concentration of BDNF in the hippocampus (Fig. 5g ).
To determine if BDNF was necessary and sufficient for IL4-rescued neurogenesis, AAV-IL4 mice were treated with K252a to block the TrkB pahway (Fig.   5h ). We found that K252a treatment blocked the increase in DCX + cells, BrdU + cells and BrdU + -DCX + cells in the hippocampus of AAV-IL4 mice subjected to the CMS paradigm ( Fig. 5i and 5j ). BDNF/TrkB signaling was blocked in vitro with either an anti-BDNF neutralizing antibody or the BDNF receptor antagonist K252a (Fig. 5k ).
As expected, both reagents were able to block the increase of NSPCs proliferation, differentiation, and migration when NSPCs were cultured in conditioned medium from microglia isolated from hippocampus of AAV-IL4 mice exposed to CMS (Fig. 5l,   5m and Fig S13) . These results suggest that BDNF is necessary for the pro-neurogenesis effects of IL4-driven microglia in CMS-exposed mice.
IL4-driven Arg1 + microglia protected mice from stress-induced depressive-like behaviors
We examined the effects of IL4 overexpression on resistance of mice to stress-induced depression using a series of behavioral tests. After 4 weeks of CMS-exposure, AAV mice showed less sucrose preference, longer immobility time in TST and FST, longer latency to feed in NSFT, and shorter time in the center in OFT than non-stressed control animals. As expected, these depressive-like behaviors were significantly absent in AAV-IL4 mice exposed to CMS (Fig. 6a and Fig. S14 ).
Through correlation analysis, we found that sucrose preference and immobility time 23 in FST were positively and negatively correlated, respectively, with the percentage of Arg1 + microglia, BDNF concentration and BrdU + -DCX + cells in the hippocampus (Fig. 6b) . Remarkably, after knockdown of microglial IL4Rα in the hippocampus, AAV-IL4 CX 3 CR1 CreER mice showed depressive-like behaviors after CMS exposure, and AAV CX 3 CR1 CreER mice showed higher stress vulnerability than control mice to the CMS paradigm ( Fig. 6c, Fig S15 and Fig. S16 ). As mentioned above, IL4-driven microglia modulate hippocampal neurogenesis in a BDNF-dependent manner in CMS-treated mice. Our experiments showed that either K252a or TMZ treatment abolished the antidepressant effects of IL4-driven microglia based on the SPT, FST, TST, and NSF (Fig. 6d, 6e and Fig. S17 ). These results suggest that IL4-driven Arg1 + microglia enhance hippocampal neurogenesis and stress resistance of CMS-exposed mice via a BDNF-dependent pathway.
Discussion
Microglia are endowed with phenotypic plasticity, which can be stimulated by different cytokines to regulate physiological responses and behavioral outcomes during stress 34, 35 . In particular, IL4 induces Arg1 + microglial phenotype and promotes neural repair 19 . The present study provides, to the best of our knowledge, the first direct evidence that IL4-driven microglia are essential for hippocampal neurogenesis and that they can mediate the resilience to chronic stress. The promotion of neurogenesis by IL4-driven Arg1 + microglia was associated with upregulation of BDNF in the hippocampus. Thus, our study demonstrates that IL4-driven Arg1 + microglia ameliorate chronic stress-induced depressive-like behaviors in mice through 24 BDNF-dependent neurogenesis.
The underlying immune environment alters the interaction between stress and inflammatory processes, thus contributing to the risk of depressive symptoms 36, 37 . In our study we found that the levels of IL4 were decreased in the hippocampus of HS mice, but increased in LS mice. Vulnerability to chronic stress is associated with dysregulation of pro-and anti-inflammatory cytokines, in particular an ineffective IL4 pathway 21 . The reduction of IL4 levels can render individuals more vulnerable to stress and more likely to engage in depressive-like behaviors. IL4 deficiency increases stress vulnerability and risk of mood disorders 20 . Our results, together with evidence from the literature 23, 38, 39 , suggest that levels of hippocampal IL4 vary inversely with stress vulnerability.
Upregulation of IL4 in the hippocampus protected mice from stress-induced depressive-like behaviors, consistent with the finding that IL4 overexpression has antidepressant effects 21 . Our transcriptome analysis showed that CMS leads to decreased expression of genes related to immune regulation (Arg1, Irf7, Irf9, etc.) and increased expression of genes related to stress response (Myoc, Cdk5rap1, etc.).
These results suggest that stress-induced depression-like behaviors are associated with neuroimmune regulation 10 . Overexpression of IL4 in the hippocampus of CMS-exposed mice leads to increased expression of a large number of immune-related genes, suggesting that increased immune regulation in the hippocampus can increase stress resistance. Among them, Arg1 is the most significantly upregulated gene, and it is co-localized with microglia. Hence, 25 overexpression of IL4 could significantly increase the number of Arg1 + microglia in hippocampus.
IL4-induced Arg1 + microglia can be thought of a special phenotype of beneficial microglia 40, 41 . These cells regulate inflammatory processes in the brain and enhance neurite growth, thereby exhibiting neuroprotective effects 27, 42, 43 . In our study, CMS-exposed mice with a lower level of hippocampal IL4 showed fewer Arg1 + microglia and higher levels of proinflammatory mediators such as IL1, TNFα, IFNγ, and iNOS. In contrast, overexpression of IL4 in the hippocampus significantly increased Arg1 + microglia and suppressed levels of proinflammatory mediators. These findings suggest that IL4-driven Arg1 + microglia reduce inflammation in the hippocampus of CMS-exposed mice by reducing the synthesis and secretion of pro-inflammatory mediators. Further, the results from flow-cytometry analysis of single cell suspensions from the whole hippocampus showed that microglia, in the form of CD45 int -CD11b + cells, increased significantly in AAV-IL4 mice. These data indicate that IL4-induced Arg1 + microglia are characterized by high proliferative activity. Furthermore, CD86 + -CD206 + microglia were significantly increased in the hippocampus of AAV-IL4 mice, suggesting that IL4 mediates neuroprotective effects in the CNS mainly by driving the phenotypic shift of microglia. Significantly, knockdown of microglial IL4Rα decreased the number of Arg1 + microglia and abrogated the antidepressant effects of IL4 overexpression, suggesting that IL4-driven Arg1 + microglia play a key role in protecting from CMS-induced depression-like behaviors. 26 Microglia constitute a prominent cell population within the hippocampal neurogenic niche 44 . Our results confirmed that CMS resulted in pro-inflammatory activation of microglia and inhibition of hippocampal neurogenesis. The transcriptome sequencing showed that overexpression of IL4 in CMS-exposed mice induced microglial pro-neurogenic phenotype and mitigated stress-induced neurogenesis impairment. Knockdown of microglial IL4Rα of mice decreased the number of Arg1 + microglia, blocked IL4-rescued hippocampal neurogenesis and stress resistance in CMS-treated mice. The data from in vitro assays showed that microglia isolated from hippocampus of CMS-exposed mice suppressed NSPCs proliferation and neurogenesis. Meanwhile, microglia isolated from hippocampus of AAV-IL4 mice were sufficient to enhance NSPCs proliferation and neuronal differentiation. These effects were not observed when IL4 was added directly to NSPCs, which indicated that IL4 rescued the impairment of adult neurogenesis in CMS-exposed mice in a microglia-dependent manner 45 24, 46, 47 . Inhibition of neurogenesis in vivo with TMZ abolished the antidepressant effects of IL4-activated microglia in CMS-treated mice. Adult hippocampal neurogenesis appears to occur in humans as well as in rodents, although this idea is still controversial [48] [49] [50] . The relatively small number of new neurons in adult brains of humans and rodents is strongly linked to the pathogenesis and remission of neuropsychiatric disorders 51 .
These findings suggest that microglia-mediated pro-neurogenesis underlies resistance to stress-induced depression.
IL4 drove microglia to adopt a phenotype of alternative activation in 27 CMS-exposed mice, associated with higher levels of BDNF release. Although BDNF/TrkB signaling was reduced in the hippocampus of CMS-exposed mice, the transcriptome sequencing with GO enrichment analysis showed BDNF signaling-related genes were enriched to a high degree in AAV-IL4 mice. Furthermore, we found that abundant BDNF is produced by Arg1 + microglia. Knockdown of microglial IL4Rα decreased the BDNF levels in the hippocampus of AAV-IL4 mice.
Blocking of BDNF/TrkB signaling with k252a blocked IL4-rescued hippocampal neurogenesis and abolished stress resistance in AAV-IL4 mice. In addition, blocking BDNF/TrkB signaling in vitro also eliminated microglia-mediated neurogenesis.
These findings suggest that the pro-neurogenesis effects of IL4-driven Arg1 + microglia depend on BDNF/TrkB signaling. Because microglia are myeloid in origin, different from nerve cells, it was believed that microglia influence neuronal behavior through non-contact-dependent pathways 52 . BDNF is an important regulator of hippocampal neurogenesis and is necessary for neurobehavioral plasticity 53, 54 . Our results suggest that the pro-neurogenesis effects and therefore the resiliency to stress of IL4-driven Arg1 + microglia depend on BDNF/TrkB signaling.
Conclusions
The present study identified critical roles of Arg1 + microglia-mediated pro-neurogenesis in the modulation of vulnerability or resistance of mice to stress.
Reprogramming microglia with IL4 can rescue hippocampal neurogenesis in stressed mice by increasing BDNF signaling. These findings indicate that regulation of microglial function is a potential therapeutic strategy for the treatment of mood 28 disorders. c, Experimental timeline of the strategy used to knockdown microglial IL4Rα combined with overexpression of IL4 and CMS exposure. CX 3 CR1 CreER mice were injected stereotactically with LV-Loxp-shIL4Rα or LV-Loxp-shRNA into the hippocampus, allowed to recover for 2 weeks, then treated with tamoxifen to induce expression of microglial IL4Rα shRNA. Finally, the animals were injected with AAV-IL4, after 2 weeks, these mice were subjected to CMS consisting of exposure to three random stressors daily for 4 weeks. 
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